𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: a preliminary study

✍ Scribed by Seiji Nakai; Tsutomu Masaki; Kazutaka Kurokohchi; Akihiro Deguchi; Mikio Nishioka


Book ID
119396849
Publisher
Nature Publishing Group
Year
2000
Tongue
English
Weight
57 KB
Volume
95
Category
Article
ISSN
0002-9270

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Ursodeoxycholic acid therapy in primary
✍ David E. J. Jones; Oliver F. W. James; Margaret F. Bassendine πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 703 KB

BackgroundlAims: A double-blind, placebo-controlled trial of ursodeoxycholic acid (UDCA) was conducted in 180 patients with primary biliary cirrhosis (PBC) to define the efficacy and safety of UDCA Efficacy was assessed by time to treatment failure defined as death; liver transplantation; histologic

A randomized trial comparing colchicine
✍ R E Poupon; P M Huet; R Poupon; A Bonnand; J T Van Nhieu; E S Zafrani πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 214 KB πŸ‘ 2 views

The efficacy of colchicine combined with ursodeoxycholic acid (UDCA) and UDCA alone in the treatment of patients with nonadvanced primary biliary cirrhosis (PBC) was evaluated in a 2-year controlled study. Seventy-four patients with PBC who had been treated previously with UDCA (at least 8 months) b